Kevzara (sarilumab)
Rheumatoid arthritis
ApprovedCommercial
Key Facts
About Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a premier biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company has built a diversified portfolio of FDA-approved treatments and maintains a robust pipeline across oncology, immunology, ophthalmology, and other therapeutic areas. Regeneron's proprietary VelociSuite technologies, including VelocImmune mice and advanced manufacturing capabilities, enable rapid drug discovery and development. With multiple billion-dollar commercial products and strong financial performance, Regeneron ranks among the most successful biotech companies globally.
View full company profileTherapeutic Areas
Other Rheumatoid arthritis Drugs
| Drug | Company | Phase |
|---|---|---|
| Early Detection Test for Rheumatoid Arthritis | Age Labs | Development |
| CORTONE (cortisone) | Merck | Commercial |
| Actemra (tocilizumab) | Chugai Pharmaceutical | Approved |
| Tocilizumab | Biocon | Filed |
| Humira | Abbott India | Approved |
| KPL-404 | Kiniksa Pharmaceuticals | Phase 2 |
| Tibulizumab (ZB-106) | Zura Bio | Phase 1b |
| Zunsemetinib (ATI-450) | Aclaris Therapeutics | Phase 2b |
| Natrunix Program | XBiotech | Not Specified |
| LEAPS Technology | CEL-SCI | Pre-clinical |
| Piclidenoson (CF101) | Can Fite Biopharma | Phase 3 |
| Targeted Immunotherapy for Rheumatoid Arthritis (via Arthritis4Cure) | LFB | Pre-clinical |